PegBio: Cornerstone Investor Extends Lock-Up on 9.58 Million H Shares to 20 May 2026

Bulletin Express04-28

PegBio Co., Ltd. disclosed on 28 April 2026 that cornerstone investor Yizekangrui Medical (HK) Limited has voluntarily prolonged its lock-up commitment on 9.58 million H shares—equivalent to 3.37% of PegBio’s total issued H shares—until 20 May 2026.

The restriction covers the entire stake acquired at the company’s listing and represents a third consecutive extension. The original six-month lock-up began on the listing date, was first pushed to 31 December 2025, then to 30 April 2026, and is now extended by an additional 20 days.

Management highlighted the extension as evidence of sustained confidence in PegBio’s R&D capabilities and progress toward key clinical milestones. The cornerstone investor will periodically reassess the company’s performance and may contemplate further extensions.

Shareholders and potential investors are advised to exercise caution when trading PegBio securities.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1140595958?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-28 18:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1140595958","market":"us","top_or_hot":-1,"title":"PegBio: Cornerstone Investor Extends Lock-Up on 9.58 Million H Shares to 20 May 2026","media":"Bulletin Express","content":"<p>PegBio Co., Ltd. disclosed on 28 April 2026 that cornerstone investor Yizekangrui Medical (HK) Limited has voluntarily prolonged its lock-up commitment on 9.58 million H shares—equivalent to 3.37% of PegBio’s total issued H shares—until 20 May 2026.</p>\n<p>The restriction covers the entire stake acquired at the company’s listing and represents a third consecutive extension. The original six-month lock-up began on the listing date, was first pushed to 31 December 2025, then to 30 April 2026, and is now extended by an additional 20 days.</p>\n<p>Management highlighted the extension as evidence of sustained confidence in PegBio’s R&D capabilities and progress toward key clinical milestones. The cornerstone investor will periodically reassess the company’s performance and may contemplate further extensions.</p>\n<p>Shareholders and potential investors are advised to exercise caution when trading PegBio securities.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>PegBio: Cornerstone Investor Extends Lock-Up on 9.58 Million H Shares to 20 May 2026</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPegBio: Cornerstone Investor Extends Lock-Up on 9.58 Million H Shares to 20 May 2026\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-04-28 18:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>PegBio Co., Ltd. disclosed on 28 April 2026 that cornerstone investor Yizekangrui Medical (HK) Limited has voluntarily prolonged its lock-up commitment on 9.58 million H shares—equivalent to 3.37% of PegBio’s total issued H shares—until 20 May 2026.</p>\n<p>The restriction covers the entire stake acquired at the company’s listing and represents a third consecutive extension. The original six-month lock-up began on the listing date, was first pushed to 31 December 2025, then to 30 April 2026, and is now extended by an additional 20 days.</p>\n<p>Management highlighted the extension as evidence of sustained confidence in PegBio’s R&D capabilities and progress toward key clinical milestones. The cornerstone investor will periodically reassess the company’s performance and may contemplate further extensions.</p>\n<p>Shareholders and potential investors are advised to exercise caution when trading PegBio securities.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02565","symbol_name":"派格生物医药-B","start_time":0,"source_url":"","article_id":"1140595958","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1140595958","pubTimestamp":1777370669,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"PegBio Co., Ltd. disclosed on 28 April 2026 that cornerstone investor Yizekangrui Medical (HK) Limited has voluntarily prolonged its lock-up commitment on 9.58 million H shares—equivalent to 3.37% of...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02565":"派格生物医药-B"},"translate_title":"培格生物：基石投资者将958万股H股锁定期延长至2026年5月20日","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02565":1},"content_text":"PegBio Co., Ltd. disclosed on 28 April 2026 that cornerstone investor Yizekangrui Medical (HK) Limited has voluntarily prolonged its lock-up commitment on 9.58 million H shares—equivalent to 3.37% of PegBio’s total issued H shares—until 20 May 2026.\nThe restriction covers the entire stake acquired at the company’s listing and represents a third consecutive extension. The original six-month lock-up began on the listing date, was first pushed to 31 December 2025, then to 30 April 2026, and is now extended by an additional 20 days.\nManagement highlighted the extension as evidence of sustained confidence in PegBio’s R&D capabilities and progress toward key clinical milestones. The cornerstone investor will periodically reassess the company’s performance and may contemplate further extensions.\nShareholders and potential investors are advised to exercise caution when trading PegBio securities.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1140595958","isCrawlerRequest":true}